FDA.reportPublic FDA data

Fabior 0.1 % Topical Foam

RxCUI
1293456
RxNorm name
Fabior 0.1 % Topical Foam
Display name
Fabior 0.1 % Topical Foam
Full name
Fabior 0.1 % Topical Foam
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FABIORTAZAROTENEMayne Pharmaae0afed7-1d60-45fd-a08b-8db0946185212026-03-03Warnings, Adverse reactionsExact identifier
rxcui: 1293456

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ae0afed7-1d60-45fd-a08b-8db094618521Fabior 0.1 % Topical Foam [PSN] · tazarotene 1 MG/ML Topical Foam [Fabior] [SBD] · Fabior 0.1 % Topical Foam [SY] · Fabior 1 MG/ML Topical Foam [SY]47These highlights do not include all the information needed to use FABIOR Foam safely and effectively. See full prescribing information for FABIOR Foam. FABIOR (tazarotene) Foam, 0 .1%, for topical use Initial U.S. Approval: 199720260303